BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1580034)

  • 1. Patient satisfaction with pharmacologic erection program.
    Hollander JB; Gonzalez J; Norman T
    Urology; 1992 May; 39(5):439-41. PubMed ID: 1580034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simplified pharmacologic erection program for patients with spinal cord injury.
    Zaslau S; Nicolis C; Galea G; Britanico J; Vapnek JM
    J Spinal Cord Med; 1999; 22(4):303-7. PubMed ID: 10751135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of intracavernous self-injection of vasoactive drugs for impotence: a long-term follow-up observation].
    Hayashi S; Iwai Y; Yasumoto R; Matsuda J; Kawano M; Omachi T; Kono T; Yamamoto S; Sakakura T; Minami H
    Hinyokika Kiyo; 1994 Jan; 40(1):37-41. PubMed ID: 7509119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intracavernous pharmacotherapy for treatment and evaluation of impotence].
    Vardi Y; Lidgi S; Moskovitz B; Levin RD
    Harefuah; 1991 Oct; 121(7-8):223-5. PubMed ID: 1783307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intracavernous injection of vasoactive drugs for treating erectile impotence].
    Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S
    Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of multidose intracorporeal injection and audiovisual sexual stimulation in vasculogenic impotence.
    Katlowitz N; Albano GJ; Patsias G; Golimbu M; Morales P
    Urology; 1993 Dec; 42(6):695-7. PubMed ID: 8256402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Papaverine-phentolamine and prostaglandin E1 versus papaverine-phentolamine alone for intracorporeal injection therapy: a clinical double-blind study.
    Shenfeld O; Hanani J; Shalhav A; Vardi Y; Goldwasser B
    J Urol; 1995 Sep; 154(3):1017-9. PubMed ID: 7637045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of a mixture of papaverine, phentolamine and prostaglandin E1 with other intracavernous injections.
    Meinhardt W; Lycklama à Nijeholt AA; Kropman RF; Vermeij P; Zwartendijk J
    Eur Urol; 1994; 26(4):319-21. PubMed ID: 7713130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prostaglandin E1 in erectile dysfunction].
    Porst H
    Urologe A; 1989 Mar; 28(2):94-8. PubMed ID: 2655258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of a second injection on the pharmaco-induced erection test.
    Pagani E; Puech-Leão P; Glina S; Reis JM
    Int J Impot Res; 1997 Sep; 9(3):167-8. PubMed ID: 9315495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic erection program for the treatment of male impotence.
    Trapp JD
    South Med J; 1987 Apr; 80(4):426-7. PubMed ID: 2436316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracavernosal therapy for erectile failure--impact of treatment and reasons for drop-out and dissatisfaction.
    Purvis K; Egdetveit I; Christiansen E
    Int J Impot Res; 1999 Oct; 11(5):287-99. PubMed ID: 10553808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impotence: treatment by autoinjection of vasoactive drugs.
    Williams G; Mulcahy MJ; Kiely EA
    Br Med J (Clin Res Ed); 1987 Sep; 295(6598):595-6. PubMed ID: 3117249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with triple-drug therapy in a pharmacological erection program.
    Govier FE; McClure RD; Weissman RM; Gibbons RP; Pritchett TR; Kramer-Levien D
    J Urol; 1993 Dec; 150(6):1822-4. PubMed ID: 8230514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3 years' experience with intracavernous auto-injection therapy].
    Weiske WH
    Urologe A; 1989 Sep; 28(5):253-6. PubMed ID: 2815435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracavernosal injection in the treatment of impotence: a prospective study of sexual, psychological, and marital functioning.
    Althof SE; Turner LA; Levine SB; Risen C; Kursh ED; Bodner D; Resnick M
    J Sex Marital Ther; 1987; 13(3):155-67. PubMed ID: 2444712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of erectile dysfunction.
    Montague DK
    J Urol; 1993 Dec; 150(6):1833. PubMed ID: 8230516
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison.
    Lee LM; Stevenson RW; Szasz G
    J Urol; 1989 Mar; 141(3):549-50. PubMed ID: 2918589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experience in the treatment of erectile impotence by the intracavernous auto-injection of vasoactive substances].
    Ferrière JM; Gaston R; Piechaud T; Le Guillou M
    Ann Urol (Paris); 1988; 22(1):57-9. PubMed ID: 3369847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drop-out reasons and complications in self-injection therapy with a triple vasoactive drug mixture in sexual erectile dysfunction.
    Casabé A; Bechara A; Cheliz G; Romano S; Rey H; Fredotovich N
    Int J Impot Res; 1998 Mar; 10(1):5-9. PubMed ID: 9542684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.